These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9875384)
21. Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain. Casimiro-Garcia A; De Clercq E; Pannecouque C; Witvrouw M; Stup TL; Turpin JA; Buckheit RW; Cushman M Bioorg Med Chem; 2000 Jan; 8(1):191-200. PubMed ID: 10968278 [TBL] [Abstract][Full Text] [Related]
22. Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics. Balzarini J; Pannecouque C; De Clercq E; Pavlov AY; Printsevskaya SS; Miroshnikova OV; Reznikova MI; Preobrazhenskaya MN J Med Chem; 2003 Jun; 46(13):2755-64. PubMed ID: 12801238 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative. Okamoto M; Fujiwara M; Kodama E; Yamamoto O; Shigeta S; Mitsuya H; Konno K; Yokota T; Baba M Antivir Chem Chemother; 1999 Mar; 10(2):71-7. PubMed ID: 10335401 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and anti-HIV activity of 4'-substituted 4'-thiothymidines: a new entry based on nucleophilic substitution of the 4'-acetoxy group. Haraguchi K; Shimada H; Tanaka H; Hamasaki T; Baba M; Gullen EA; Dutschman GE; Cheng YC J Med Chem; 2008 Mar; 51(6):1885-93. PubMed ID: 18311897 [TBL] [Abstract][Full Text] [Related]
25. Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells. Lemaître M; Guétard D; Hénin Y; Montagnier L; Zerial A Res Virol; 1990; 141(1):5-16. PubMed ID: 2326552 [TBL] [Abstract][Full Text] [Related]
26. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Pauwels R; Andries K; Desmyter J; Schols D; Kukla MJ; Breslin HJ; Raeymaeckers A; Van Gelder J; Woestenborghs R; Heykants J Nature; 1990 Feb; 343(6257):470-4. PubMed ID: 1689015 [TBL] [Abstract][Full Text] [Related]
27. 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family. Mai A; Artico M; Ragno R; Sbardella G; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; Maga G; La Colla P Bioorg Med Chem; 2005 Mar; 13(6):2065-77. PubMed ID: 15727860 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Zhang J; Zhan P; Wu J; Li Z; Jiang Y; Ge W; Pannecouque C; De Clercq E; Liu X Bioorg Med Chem; 2011 Jul; 19(14):4366-76. PubMed ID: 21683601 [TBL] [Abstract][Full Text] [Related]
29. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro. Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638 [TBL] [Abstract][Full Text] [Related]
36. Anti-AIDS agents. Part 61: Anti-HIV activity of new podophyllotoxin derivatives. Zhu XK; Guan J; Xiao Z; Cosentino LM; Lee KH Bioorg Med Chem; 2004 Aug; 12(15):4267-73. PubMed ID: 15246103 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of novel MKC-442 analogues with potent activities against HIV-1. El-Brollosy NR; Pedersen EB; Nielsen C Arch Pharm (Weinheim); 2003 Jul; 336(4-5):236-41. PubMed ID: 12916058 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, anti-human immunodeficiency virus activity and esterase lability of some novel carboxylic ester-modified phosphoramidate derivatives of stavudine (d4T). McGuigan C; Sutton PW; Cahard D; Turner K; O'Leary G; Wang Y; Gumbleton M; De Clercq E; Balzarini J Antivir Chem Chemother; 1998 Nov; 9(6):473-9. PubMed ID: 9865385 [TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication. King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720 [TBL] [Abstract][Full Text] [Related]
40. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]